Science · 2021 · 182 citations · 25 references
Life SciencesImmunologyOncologyCancer ImmunologyCell SignalingSignal TransductionAntigen RecognitionAntitumor T Cell ResponsesCancer ImmunotherapyCytotoxic T Lymphocyte ResponsesT Cell ActivationT Cell BiologyAffinity EngineeringSynthetic Receptor EngineeringT Cell Receptor EngineeringT Cell-mediated Tumor KillingT-cell Responses To Tumor AntigensTumor Antigen RecognitionUltrasensitive DetectionUltrasensitive Responses
Overexpressed tumor-associated antigens [for example, epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2)] are attractive targets for therapeutic T cells, but toxic "off-tumor" cross-reaction with normal tissues that express low levels of target antigen can occur with chimeric antigen receptor (CAR)-T cells. Inspired by natural ultrasensitive response circuits, we engineered a two-step positive-feedback circuit that allows human cytotoxic T cells to discriminate targets on the basis of a sigmoidal antigen-density threshold. In this circuit, a low-affinity synthetic Notch receptor for HER2 controls the expression of a high-affinity CAR for HER2. Increasing HER2 density thus has cooperative effects on T cells-it increases both CAR expression and activation-leading to a sigmoidal response. T cells with this circuit show sharp discrimination between target cells expressing normal amounts of HER2 and cancer cells expressing 100 times as much HER2, both in vitro and in vivo.
25
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
Sattva S. Neelapu, Frederick L. Locke, Nancy L. Bartlett et al. · New England Journal of Medicine · 2017 · 5.9K citations · Full text
Medicine, Hematology, Oncology +16
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
Shannon L. Maude, Theodore W. Laetsch, Jochen Buechner et al. · New England Journal of Medicine · 2018 · 5.6K citations · Full text
Medicine, Hematology, Oncology +17
Human chimeric antigen receptor macrophages for cancer immunotherapy
Michael Klichinsky, Marco Ruella, Olga Shestova et al. · Nature Biotechnology · 2020 · 1.4K citations · Full text
Life Sciences, Immunology, Oncology +14